Temporal trends in first-line chemotherapy treatment among elderly stage IIIB/IV non-small cell lung cancer (NSCLC) patients in the United States: Evidence from SEER-Medicare data

被引：0
|
作者：
Lang, K.
Marciniak, M. D.
Faries, D.
Stokes, M.
Buesching, D.
Earle, C.
Treat, J.
Thompson, D.
机构：
[1] i3 Innovus, Medford, MA USA
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
[3] United BioSource Corp, Medford, MA USA
[4] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
17002
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Trends and predictors of first-line chemotherapy use among elderly patients with advanced non-small cell lung cancer in the United States
    Lang, Kathleen
    Marciniak, Martin D.
    Faries, Doug
    Stokes, Michael
    Buesching, Don
    Earle, Craig
    Treat, Joseph
    Morissette, Nathalie
    Thompson, David
    [J]. LUNG CANCER, 2009, 63 (02) : 264 - 270
  • [2] Adjuvant Chemotherapy for Elderly Patients With Stage I Non-Small Cell Lung Cancer (NSCLC) With Tumors ≥ 4 cm: A SEER-Medicare Analysis
    Malhotra, J.
    Mhango, G.
    Gomez, J. E.
    Smith, C. B.
    Galsky, M. D.
    Strauss, G. M.
    Wisnivesky, J. P.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S56 - S56
  • [3] Irinotecan and docetaxel as first-line chemotherapy in patients with stage IIIB/IV non-small cell lung cancer.
    Raez, LE
    Rosado, M
    Santos, ES
    Hamilton, K
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 677S - 677S
  • [4] Adjuvant chemotherapy for elderly patients with stage I non-small cell lung cancer (NSCLC) with tumors ≥4 cm: A SEER-Medicare analysis.
    Malhotra, Jyoti
    Mhango, Grace
    Gomez, Jorge E.
    Smith, Cardinale B.
    Galsky, Matt D.
    Strauss, Gary M.
    Wisnivesky, Juan P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [5] Utility of surveillance imaging in stage III non-small cell lung cancer (NSCLC) patients: A SEER-Medicare analysis
    Thakur, Manish K.
    Ruterbusch, Julie
    Schwartz, Ann G.
    Beebe-Dimmer, Jennifer Lynn
    Holowatyj, Andreana N.
    Wozniak, Antoinette J.
    Gadgeel, Shirish M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [6] A phase II study of pemetrexed and gemcitabine plus bevacizumab as first-line chemotherapy for elderly patients with stage IIIb/IV non-small cell lung cancer
    Blakely, L.
    Schwartzberg, L. S.
    Schnell, F. M.
    Sabbath, K. D.
    Miller, P. J.
    Stepanski, E. J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [7] Trends in treatment among elderly colorectal cancer patients in the US: Evidence from linked SEER-Medicare data
    Lang, K.
    Lines, L. M.
    Lee, D. W.
    Korn, J. R.
    Vanness, D. J.
    Earle, C.
    Menzin, J.
    [J]. VALUE IN HEALTH, 2008, 11 (03) : A9 - A9
  • [8] First-line treatment and lifetime medical-care costs among elderly stage IIIB/IV non-small cell lung cancer (NSCLC) patients treated with commonly used doublet therapies
    Lang, K.
    Marciniak, M.
    Faries, D.
    Stokes, M. E.
    Buesching, D.
    Earle, C.
    Treat, J.
    Babineaux, S.
    Thompson, D.
    [J]. VALUE IN HEALTH, 2007, 10 (03) : A130 - A130
  • [9] Chemotherapy beyond first-line in stage IV metastatic non-small cell lung cancer
    Younes, Riad Naim
    Pereira, Jost Rodrigues
    Fares, Abdo Latif
    Gross, Jefferson Luiz
    [J]. REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2011, 57 (06): : 686 - 691
  • [10] SURVIVAL AND COST OF CARE BY TYPE OF FIRST-LINE THERAPY IN METASTATIC NON-SMALL LUNG CANCER USING SEER-MEDICARE DATA
    Danese, M.
    Lee, A.
    Su, I. H.
    Penrod, J. R.
    Yuan, Y.
    [J]. VALUE IN HEALTH, 2024, 27 (06) : S21 - S21
12345